HANCOCK WHITNEY CORP - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$321,000
-82.4%
15,908
-67.4%
0.01%
-81.0%
Q2 2021$1,821,000
+40.0%
48,806
-4.1%
0.06%
+31.8%
Q1 2021$1,301,000
+55.1%
50,897
+33.6%
0.04%
+57.1%
Q4 2020$839,000
-4.0%
38,095
-21.6%
0.03%
-12.5%
Q3 2020$874,000
-30.0%
48,591
-1.2%
0.03%
-33.3%
Q2 2020$1,249,000
+21.6%
49,186
-12.0%
0.05%
+20.0%
Q1 2020$1,027,000
-31.1%
55,912
-17.4%
0.04%
-16.7%
Q4 2019$1,491,00067,6620.05%
Other shareholders

There were no reported owners of DICERNA PHARMACEUTICALS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of DICERNA PHARMACEUTICALS INC shareholders